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Primary Pulmonary T-Cell Lymphoma: 
a Case Report
Primary pulmonary T-cell lymphoma is an extremely rare malady, and we diag-
nosed this in a 52-year-old male who was admitted to our hospital with cough for
the previous two weeks. The chest CT demonstrated multiple variable sized
mass-like consolidations with low density central necrosis in the peripheral por-
tion of both the upper and lower lobes. Positron emission tomography (PET)
showed multiple areas of hypermetabolic fluorodeoxyglucose (FDG) uptake in
both lungs with central metabolic defects, which correlated with central necrosis
seen on CT. The histological sample showed peripheral T-cell lymphoma of the
not otherwise specified form. The follow-up CT scan showed an increased extent
of the multifocal consolidative lesions despite that the patient had undergone
chemotherapy.
rimary lymphoma of the lung is a rare disorder, and primary pulmonary
lymphoma represents only 0.5-1% of all primary pulmonary malignan-
cies, less than 1% of all the cases of non-Hodgkin’s lymphoma (NHL) and
3-4% of all the extranodal manifestations of NHL (1). Most of the cases of the
primary lymphoma of the lung originate from the B-cell lineage, and the disease is
frequently located in the bronchus-associated lymphoid tissue. Very few cases of
pulmonary T-cell lymphoma have been reported and the imaging features of this rare
cancer have not been well characterized. 
We report here on an extremely rare case of primary pulmonary peripheral T-cell
lymphoma not otherwise specified (PTCLN), and we present the CT and positron
emission tomography (PET) images.
CASE REPORT
A 52-year-old male was admitted to our hospital suffering with cough, fever and
sweating for the previous two weeks. There was no history of treatment or medication
for diabetes mellitus and hypertension. The patient was a smoker (45 pack-years) and
he drank alcohol.
On the posteroanterior chest radiograph, variable sized nodules and masses were
seen in both lower lobes and the right upper lobe (Fig. 1A). The contrast enhanced
chest CT scan revealed variable sized masses in the right upper lobe and both lower
lobes, and the masses displayed central necrosis (Fig. 1B-D). A small fluid collection
was seen in the left hemithorax. No endobronchial lesion was visualized on
bronchoscopy. A CT-guided percutaneous transthoracic needle biopsy (PTNB) was
done for the mass in the left lower lobe.
The histologic examination of the percutaneous transthoracic needle biopsy
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Pspecimen showed diffuse infiltrates of large lymphoid cells
(Fig. 1E). The tumor cells had pleomorphic, irregular nuclei
and prominent nucleoli (Fig. 1F). Mitoses were easily
observed, including some atypical forms.
Immunohistochemical staining demonstrated that the
tumor cells were positive for CD3 (Fig. 1G) and they were
negative for CD20, CD30 (Ki-1) and CD56. The Ki-67
labeling index was more than 70%. The pathologic diagno-
sis was peripheral T-cell lymphoma not otherwise
specified.
We evaluated the patient for the presence of lymphoma
involvement of other organs. Bone marrow aspiration and
biopsy were both performed. The specimen showed nearly
normal, fully matured myeloids and an adequate number
of megakaryocytes without lymphomatous involvement.
18F-fluoro-2-deoxyglucose positron emission tomogra-
phy (FDG-PET) showed multiple hypermetabolic masses
with photopenic defects (maxSUV 8.9) in both lungs (Fig.
1H). There was no evidence of mediastinal lymph node
uptake or extrapulmonary uptake. Finally, we diagnosed
the patient as suffering with primary pulmonary peripheral
T-cell lymphoma not otherwise specified.
After chemotherapy, the B symptoms that included fever
and sweating subsided. The follow-up contrast enhanced
chest CT scan obtained two months after the initial diagno-
sis showed aggravated T-cell lymphoma involvement in
the lungs (Fig. 1I-K).
We observed multifocal irregular enhancing lesions in
both parietal cortical areas on the brain CT and MRI
obtained four months after the initial diagnosis and this all
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Fig. 1. 52-year-old male patient. 
A. On posteroanterior chest radiograph, variable sized large, round increased opacities are seen in both lower lobes and right upper lobe
(arrow). Well defined linear increased opacity with architectural distortion is seen at posterior segment of left upper lobe.
B-D. Contrast enhanced chest CT scan reveals variable sized masses in right upper lobe (B) and in both lower lobes (C, D) with portion
of central necrosis. Small fluid collection is seen in left hemithorax (C, D).
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Fig. 1. 52-year-old male patient. 
E. Percutaneous transthoracic needle biopsy specimen shows
diffuse infiltrates of large atypical lymphoid cells (Hematoxylin &
Eosin staining, ×100). 
F. Tumor cells are large with pleomorphic, irregular nuclei and
prominent nucleoli (Hematoxylin & Eosin staining, ×400). 
G. Immunohistochemical staining of tumor cells revealed diffuse
and strong positivity for cytoplasmic CD3 (Hematoxylin & Eosin
staining, ×200).
H. Staging whole torso PET scan revealed intensely hypermeta-
bolic lung mass with central metabolic defects. There was no
evidence of mediastinal lymph node uptake or extrapulmonary
uptake.
G
Hsuggested multiple parenchymal and meningeal metastases.
Sadly, the patient eventually expired from pneumonia
during ICU care after multiple episodes of neutropenic
fever. 
DISCUSSION
Primary pulmonary lymphoma is diagnosed according to
the following strict criteria: 1) the lung, bronchus or both
are involved without evidence of mediastinal adenopathy
or a mass on the chest radiographs, 2) extrathoracic
lymphoma was not previously diagnosed and 3) there was
no evidence of extrathoracic lymphoma or lymphatic
leukemia at the time that primary lymphoma of the lung
was diagnosed. Further, for making the diagnosis of
primary pulmonary lymphoma, the disease is not present
outside of the thorax for least three months after the initial
diagnosis (2). Low-grade B-cell lymphoma is the most
frequent form of primary pulmonary lymphoma; however,
primary pulmonary peripheral T-cell lymphoma is
extremely rare.
Peripheral T-cell lymphoma (PTCL) comprises a group of
rare, aggressive cancers that develop from T-cells that are
at different stages of maturity. The World Health
Organization (WHO) has divided the various types of
PTCL into two main categories: 1) precursor T-cell
neoplasms, which include precursor T-lymphoblastic
lymphoma/leukemia; and 2) peripheral T-cell neoplasms,
which are subcategorized as predominantly leukemic
disease, predominantly disseminated disease, predomi-
nantly extranodal disease and predominantly nodal
disease. The cases that do not match one of the defined
entities of PTCL are best categorized as ‘not otherwise
specified’, reflecting the fact that we do not yet understand
everything about lymphomas or the immune system (3). 
The incidence of PTCL tends to be higher in Korea (25%
of the cases of NHL) than in Europe (10-15% of the cases
of NHL), as well as the incidence of peripheral T-cell
lymphoma not otherwise specified (PTCLN) is higher in
Korea (11% of the cases of NHL) that in Europe (4% of
the cases of NHL) (3, 4). 
Patients with PTCLN are usually adults with generalized
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Fig. 1. 52-year-old male patient. 
I-K. Contrast enhanced chest CT scan obtained two months after
initial diagnosis shows that large mass in left lower lobe has
increased in size with large areas of necrosis and multiple air spots
(J). Multiple nodules with necrosis have increased in extent in right
upper lobe and right lower lobe. Fluid collection in left hemithorax
has increased in amount (I, K).
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disease; the lymph nodes, liver and spleen may be
involved. Most of the cases present with cough and
dyspnea. The most common radiologic finding of PTCLN is
generalized lymphadenopathy (3, 5). In patients with
disseminated conditions, the imaging features are not
distinguishable from those of the other subtypes of
lymphoma in the disseminated state. 
Our case shows a very unique feature of primary
pulmonary PTCLN as the disease presented as multiple
lung masses with central necrosis and there was no disease
involvement at any other site on the detailed work up. The
radiologic appearance of central necrosis in the consolida-
tion or mass can also present in such benign conditions as
abscess, lung infarction, c-ANCA (anti-neutrophil cytoplas-
mic antibody)-associated granulomatous vasculitis and
carcinomas. The thick wall and irregular inner margin are
more frequently seen in malignant lesions, as was noted in
our case. The cavitation in lymphoma is probably due to
central ischemic necrosis. This may be due to the rapid
tumor growth and it tends to occur in large nodules and
masses. A cavity with air-fluid levels may be apparent
when there is communication between an adjacent
bronchus and a necrotic tumor mass.
There has been a report about extranodal PTCL showing
a pattern of photopenic defect on PET scanning, like was
seen in our case (6). This photopenic defect correlates well
with central necrosis, yet necrosis is an uncommon PET
scan finding for lymphoma. Tumor necrosis generally
correlates with hypoxia and it is a predictor of a poor
prognosis for patients with malignant tumor. Tumor
hypoxia plays a major role in tumor progression and
resistance to treatment, like what happened in our case (6).
For most of the subtypes of PTCL, the treatment
regimen is typically CHOP-based chemotherapy
(cyclophosphamide, doxorubicin, vincristine and
prednisone), or EPOCH (etoposide added to CHOP) in the
frontline setting (7). Adult T-cell leukemia or lymphoma
has a poor prognosis due to the life-threatening complica-
tions that include infections and hypercalcemia (8). The
clinical course is usually aggressive, and relapses are more
common for T-cell leukemia or lymphoma than for the B-
cell lymphomas of a similar histologic grade (9, 10). We
report herein on a rare case of PTCL and we present the
CT and PET images of this often fatal neoplasm. 
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